Strategic Alliance between Eve Technologies and CNBE INRS


Calgary and Laval, December 11, 2017. – A strategic partnership agreement in biomarker discovery has been signed by Eve Technologies and Centre national de biologie expérimentale (CNBE) of Institut national de recherche scientifique (INRS). This unique alliance provides integrated contractual services for animal studies and biomarker identification.

Eve Technologies, with over 15 years of experience, is committed to providing biomarker analysis from animal samples generated and collected by CNBE. Through CNBE you can now utilize their services and animal research facility and obtain biomarker analysis through Eve Technologies is a cost-effective and streamlined process.


CNBE, located on the INRS Research University campus in Laval, Québec, Canada, offers high standard preclinical animal research services to the scientific community and the biotechnology and pharmaceutical industries. Certified by the Canadian Council on Animal Care in Science (CCAC) and the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International), it provides housing for laboratory animals at various levels of biological confinement as well as an array of services required by R&D projects and drug development. Specifically, CNBE specializes in drug metabolism / pharmacokinetic studies, toxicity studies, and drug efficacy in animal models.
In this partnership, CNBE brings over 22 years of experience and is responsible for the in-life component of animal research including drug administration, clinical assessment, and blood and sample collections. CNBE has expertise with many animal species from rodents to large animals to non-human primates.

About Eve Technologies Corp 

Eve Technologies is an independent corporation based in Calgary, AB, Canada that solely exists to partner with biomedical and life science researchers. To best serve our clients, we have focused on gaining expertise in the most effective assay technology that we know of – multiplexing laser beads. By utilizing this technology, Eve Tech aims to provide the biomedical and life science community with the highest quality assay services at the most cost-effective prices.  As a result of developing advanced assay techniques, employing automation and forming strong relationships with suppliers, we offer the most affordable assay services in the industry. As a result, Eve Technologies has become a biomarker leader in the industry assisting over 1000 research institutions with the best biomarker analysis solutions for their projects.